The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 10, 2024

Filed:

Dec. 06, 2022
Applicants:

The Rockefeller University, New York, NY (US);

Inspirna, Inc., New York, NY (US);

Inventors:

Sohail F. Tavazoie, New York, NY (US);

Masoud Tavazoie, New York, NY (US);

Nils Henrik Halberg, Bergen, NO;

Assignees:

The Rockefeller University, New York, NY (US);

Inspirna, Inc., Long Island City, NY (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); A61K 47/68 (2017.01); A61P 35/00 (2006.01); C07K 16/40 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2863 (2013.01); A61K 39/001154 (2018.08); A61K 39/3955 (2013.01); A61K 47/68031 (2023.08); A61K 47/6817 (2017.08); A61P 35/00 (2018.01); C07K 16/40 (2013.01); A61K 45/06 (2013.01);
Abstract

The present disclosure provides antibody-drug conjugates comprising (i) antibodies that specifically bind to Mer Tyrosine Kinase (MERTK) (e.g., human MERTK, or both human and mouse MERTK), and (ii) cytotoxic agents conjugated directly to the antibodies or conjugated to the antibodies via linkers, and compositions comprising such antibody-drug conjugates, wherein the antibodies contained in the antibody-drug conjugates agonize MERTK signaling of endothelial cells. The present disclosure also provides methods for treating cancer, by administering an antibody-drug conjugate that comprises (i) an antibody that specifically binds to MERTK and agonizes MERTK signaling of endothelial cells, and (ii) a cytotoxic agent conjugated directly to the antibody or conjugated to the antibody via a linker.


Find Patent Forward Citations

Loading…